They say, quality is its own reward. And in fact it is impossible to buy a toilet at Home Depot that is not developed and manufactured following a quality system. Regulated manufacturers must follow the FDA's quality system, which is similar to ISO9001. A review of your current company policies and procedures results in a quality system gap analysis. Next, a plan details the process and time required to implement the quality system. The least disruptive and lowest cost approach is to take 6 months or more to implement your quality system. The implementation plan is executed along a series of milestones including policies, procedures, forms, training and guidance during implementation.
Regulatory issues for many companies exist somewhere in the gray zone of regulatory uncertainty. Choices made for the intended use, marketing claims, and product classification — along with certain product features — are all interrelated. Finding the optimal regulatory strategy is an iterative process, weighing trade-offs carefully.
Once your strategy is defined, it is time to execute. Our experience helps assure that your quality system and resulting artifacts will meet FDA scrutiny during an FDA inspection or review of a submission.
If you've never been regulated, its not as bad as you imagine — but it is important to have someone who can show you the way.
For many, it is not clear whether their product is a regulated medical device. What follows is the legal definition of a medical device.
If a product is labeled, promoted or used in a manner that meets the following definition in section 201(h) of the Federal Food Drug & Cosmetic (FD&C) Act it may be regulated by the FDA as a medical device and subject to premarketing and postmarketing regulatory controls.
A device is: "an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part, or accessory which is:
which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of its primary intended purposes. The term "device" does not include software functions excluded pursuant to section 520(o)."
Under sections 520(o)(1)(A)-(D) of the FD&C Act (21 U.S.C. 360j(o)(1)(A)-(D)), as added by the 21st Century Cures Act, certain medical software functions are not medical devices, including software functions that are intended (1) for administrative support of a health care facility, (2) for maintaining or encouraging a healthy lifestyle, (3) to serve as electronic patient records, or (4) for transferring, storing, converting formats, or displaying data.
Besides conventional medical devices, a regulated device can include application software and even services.
The definition of a medical device is very inclusive. This broad definition is balanced against the FDA's limited resources which cannot possibly regulate every product that meets the legal definition. A key factor, among several that the FDA uses to best focus their resources is patient safety. Other examples of enforcement discretion are described below.
Products sold into health care can be divided into three areas: those that are clearly regulated, a large gray area where there is some ambiguity whether a product is regulated or not, and those products that are clearly not regulated.
Hardware and software products clearly meeting the legal definition of a medical device are regulated. The is an extensive body of regulated hardware from pacemakers to patient monitors to patient beds to tongue depressors. FDA has regulated application software for many years. Examples include software for calculating insulin doses for tight glycemic control, software that detects diagnostic abnormalities in x-rays or MRI scans, and certain clinical decision support software. Medical device systems, such as smart pumps, made up of medical devices, server software and client applications are all regulated as a single medical device system.
Adding connectivity to embedded system medical devices introduces a new kind of technology — network enablement, application software and off-the-shelf computer equipment — that often requires a regulatory strategy different from the embedded system device itself.
There are many levers available to manufacturers and the FDA to determine whether a product is regulated or not. The following are just four examples of scenarios where the regulatory question could be answered either way.
Some products can be regulated or not depending on how they are labeled, promoted or used. A wireless home weight scale and associated smartphone app intended for weight loss by those seeking health improvement are not regulated. The same wireless weight scale and smartphone app intended to monitor weight changes for congestive heart failure patients is a regulated medical device. It is up to the manufacturer to determine which marketing claims and intended use will generate the most sales and profit for their product — in this case, a general health and wellness claim or a chronic disease management claim.
In a related example, sometimes new products developed by regulated medical device manufacturers for use with their regulated products are not regulated. Despite FDA's final guidance on accessories, some manufacturer's HL7 integration engines intended to transfer medical device data into the patient's EMR record are not regulated devices. While such a product clearly meets the definition for a medical device accessory (and consequently would be regulated to the same extent as the medical device to which it is an accessory) some of these products are not regulated while some are.
Some product categories have competitors who are regulated and some who are not. Nurse call systems and hospital supply chain dispensing cabinets are two examples. In both of these markets, some manufacturers have their products regulated by the FDA and some do not. Some may chose to be regulated when they don't really have to for convenience, as a way to to create a competitive barrier to entry, to meet a buyer preference for a regulated product or to be able to make certain marketing claims that push the product into regulated territory.
Emerging technologies and related markets often start out as regulatory gray areas. Examples of current gray areas for emerging technology and markets include some digital health applications, clinical decision support systems and artificial intelligence solutions. When innovative new solutions come to market for which there are no pre existing established products, the FDA will typically exercise enforcement discretion (choose not to enforce the regulations) and observe the market develop (with particular focus on patient safety). As the market matures and adoption increases the FDA will eventually step in, announce they are planning to regulate and how, and provide the market with dates vendors need to meet to come into compliance. In these cases, companies can start without the full regulatory burden while they (and the market) get established. But eventually they will need to make the changes required to become regulated — when and how they make that transition are important considerations. Typically FDA does not explicitly state that they are pursuing enforcement discretion in a particular emerging market, but they have made public statements with regards to digital health.
Since then, regulatory issues have been a key part of my focus in product life cycle management. I have made it my business to cultivate a deep understanding of regulatory affairs and how regulatory strategy impacts product success. I've been consulting and writing about regulatory issues for for more than 10 years and the blog posts listed below provide examples of some of my knowledge and understanding of regulatory issues.
Another health care lifer, Patricia brings over 25 years in medical device product development and marketing. Besides working for companies who ran a tight ship regulatory-wise, she also worked for a manufacturer under an FDA consent decree precluding the manufacturer from shipping product. Here there was a heightened focus on regulatory compliance where she worked on product development, labeling and marketing.
Regulatory issues have been a key part of Patricia's work for the past 25+ years. Quality system artifact creation, the product development process and labeling have been her focus — along with seeking opportunities for continuous improvement from good to great.
The impact when you are regulated by the FDA is real, but may be less than you imagine. Being regulated means you must do these four things:
The following articles provide some background, analysis and a bit of prognostication on regulatory issues.